# Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes

> **NCT03625518** · EARLY_PHASE1 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 280 (estimated)

## Conditions studied

- Fetal Growth Retardation
- Induction of Labor Affected Fetus / Newborn

## Interventions

- **DRUG:** prostaglandins E2
- **DEVICE:** intracervical balloon catheter combined with pitocin

## Key facts

- **NCT ID:** NCT03625518
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2020-07
- **Final completion:** 2021-01
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625518, "Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03625518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*